No Detail Found!

Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population

Author(s)
Tabinda Najeeb Department of Physiology, Baqai Medical University, Karachi, Pakistan
Mohammad Saleh Soomro (late) Department of Physiology, Baqai Medical University, Karachi, Pakistan
Asher Fawwad Department of Biochemistry, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan
Nazish Waris Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan
Ruqaya Nangrejo Department of Physiology, Baqai Medical University, Karachi, Pakistan
Iftikhar Ahmed Siddiqui Department of Biochemistry, Baqai Medical University, Karachi, Pakistan.
Qamar Aziz Department of Physiology, Baqai Medical University, Karachi, Pakistan
Abdul Basit Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan
Abstract
Objective:To evaluate the impact of hepcidin and ferritin in pathogenesis and prognosis of type 2 diabetes mellitus subjects taking only metformin or combined anti-glycaemic agents. Methods: The observational case-control study was conducted at the Department of Physiology, Baqai Medical University, Karachi, from August 2019 to October 2020, and comprised subjects from both genders who categorised into equal groups as non-diabetic controls, newly-diagnosed type 2 diabetes mellitus patients without any treatment, type 2 diabetes mellitus patients with exposure to metformin only, type 2 diabetes mellitus patients taking oral hypoglycaemic agents along with metformin, type 2 diabetes mellitus patients taking only insulin, and type 2 diabetes mellitus patients taking insulin and oral hypoglycaemic agents. Fasting plasma glucose was determined using glucose oxidase-peroxidase method, glycated haemoglobin by high performance liquid chromatography, high-density lipoprotein and low-density lipoprotein by direct methods, cholesterol by cholesterol oxidase phenol 4-amino antipyrine peroxidase and triglycerides by glycerol phosphate oxidase-phenol 4-amino antipyrine peroxidase method. Serum levels of ferritin, insulin and hepcidin were evaluated using Enzyme-linked immunosorbent assay. Insulin resistance was assessed using homeostasis model assessment for insulin resistance. Data was analysed using SPSS 21. Results: Of the 300 subjects, there were 50(16.66%) in each of the 6 groups. Overall, there were 144(48%) males and 155(51.66%) females. The mean age was signifi cantly lower in the control group 34.72±7.87 compared to all the diabetic groups (p0.05). Besides, hepcidin level was signifi cantly higher in the control group (p<0.05). Ferritin levels were signifi cantly increased in newly-diagnosed T2DM subjects compared to the controls (p<0.05) while all other groups showed decreased ferritin levels (p<0.05). Hepcidin gave inverse correlation with glycated haemoglobin only in diabetics taking only metformin (r = -0.27, p=0.05). Conclusion: Anti-diabetes drugs not only addressed type 2 diabetes mellitus, but also reduced levels of ferritin and hepcidin that are found to play a role in diabetes development.
Publication Details
Page(s) 313-318
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 73, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Insulin, Hepcidin, hepcidin, Ferritin, T2DM., Oral hypoglycaemic agents
0

Citations

0

Downloads

125

Views